Skip to content
CNS Clinical Research

Research area

Parkinson's Disease clinical trials

Investigational medications, devices, and exercise or therapy programs for movement and non-movement symptoms are what Parkinson's disease studies examine. With CNS Clinical Research, you can find out whether one of those studies may be a fit for you.

Updated

Call (888) 520-7418
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Parkinson's disease studies in numbers

Parkinson's disease studies recruiting in the U.S.
247
states with a study site
50
studies that accept healthy volunteers
56

Source: ClinicalTrials.gov. Data processed .

Find Parkinson's disease studies by state

These states have the most studies recruiting right now.

Parkinson's disease studies recruiting now

As of November 16, 2026, 247 Parkinson's disease studies are recruiting participants in the United States, according to ClinicalTrials.gov. This is what they have in common.

What they test

  • medications72
  • devices68
  • other approaches42
  • behavioral approaches such as talk therapy or training33
  • biologics such as vaccines or antibodies18

A study can test more than one.

Main purpose

  • treating a condition121
  • basic science31
  • diagnosis19
  • other purposes8

Phase

  • Early Phase 110
  • Phase 117
  • Phase 1/214
  • Phase 227
  • Phase 2/32
  • Phase 311
  • Phase 49
  • No phase103
  • Observational54

Studies of devices and behavioral approaches have no phase.

Who runs them

  • university, hospital or other175
  • industry58
  • government14

Who they enroll

  • adults (18 to 64)247
  • older adults (65 and over)246
  • children (under 18)17

56 also accept healthy volunteers.

These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.

Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 247 studies.

Recently updated Parkinson's disease studies

The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.

  1. DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

    • Phase 3
    • Ages 18 and older
    • Female participants
    Sponsor
    AstraZeneca
    Recruiting in
    Ann Arbor, MI · Arlington Heights, IL · Austin, TX · and 39 more U.S. locations
    Registry record
    NCT06989112 · updated
  2. Using taVNS to Modulate Cardiovascular Function in Individuals With Neurologic Disease

    • Phase 1
    • Ages 18 to 80
    • All sexes
    Sponsor
    University of Alabama at Birmingham
    Recruiting in
    Birmingham, AL
    Registry record
    NCT07557706 · updated
  3. Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease

    • Phase 2
    • Ages 40 to 85
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Recruiting in
    Boca Raton, FL
    Registry record
    NCT07781644 · updated
  4. Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    East Syracuse, NY · Grand Rapids, MI · Houston, TX · and 3 more U.S. locations
    Registry record
    NCT06469944 · updated
  5. Neocortical Microarchitecture of Executive Function

    • No phase
    • Ages 45 to 85
    • All sexes
    Sponsor
    University of Colorado, Denver
    Recruiting in
    Aurora, CO
    Registry record
    NCT06778135 · updated
  6. Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments

    • Phase 1/2
    • Ages 45 and older
    • All sexes
    Sponsor
    Prabesh Kanel
    Recruiting in
    Ann Arbor, MI
    Registry record
    NCT07154511 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in the United States on ClinicalTrials.gov.

What Parkinson's disease studies look at

Studies of Parkinson's disease look at investigational medications, devices, and exercise or therapy programs aimed at movement and non-movement symptoms. Every study is built around one specific question. That is why the things you would be asked to do change from one study to the next.

Whatever a study is testing is investigational. Researchers are still learning how well it works and what risks it carries, and that is exactly why the study is being run.

Who may be able to take part

Each Parkinson's disease study sets requirements of its own. Your age, your health history, the medications you currently take, and the effect Parkinson's disease has on you can all be part of them. Some studies also take volunteers who do not have Parkinson's disease at all.

Sorting out whether you fit is not your job. The study team does that check with you at a screening visit. Read how eligibility and screening work.

What taking part usually involves

  1. A first conversation

    Before anything else happens, a coordinator walks you through the study in general terms and answers the questions you have.

  2. Informed consent

    The study team hands you a written explanation covering every detail of the study, and it spells out the risks that are known. Whether you agree is your call.

  3. Screening

    You answer questions about your health and have tests, and the results show if this study fits you. Being screened does not always lead to taking part.

  4. Study visits

    Should you decide to join a Parkinson's disease study, you come in for planned appointments, and those give the study team a way to follow your health. Taking part stays voluntary. You can stop whenever you choose.

Questions about Parkinson's disease studies

Do I need a diagnosis to join a study about Parkinson's disease?

Each study handles this differently. For some, you must already have a confirmed diagnosis. For others, the assessment happens at screening. Which rule applies to you is something the study team will explain.

Would I have to change the care I receive now?

Keep your current care as it is and do not change anything on your own. Whether current care can continue depends on the study: some allow it and others do not. The study doctor goes over this with you, and you can discuss it with your own doctor before you decide.

Is there a cost to take part?

As a participant, you generally do not pay for study visits, study tests, or the study medication. Read more about costs.

Ask about Parkinson's disease studies

Send a few details and a coordinator will follow up with you. Making an enquiry carries no obligation, so you stay free to say no.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Independent information

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 520-7418

or send a short form

How should we reach you?

Call